David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 500 shares at $29.68 ($15K) on 2025-01-29, disclosed to the SEC on 2025-01-31.
Scheduled sale ($15k) by SVP, Life Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |